ÇelikMSökmenESivriSUçarCNarRErerM. The relationship between serum endocan level and aortic elastic properties in patients with newly diagnosed essential hypertension. Angiology. 2019;70(7):662–8.
2.
BaltaSMikhailidisDPDemirkolS. Endocan—a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study. Angiology. 2014;65(9):773–7.
3.
IcliACureECureMC. Endocan levels and subclinical atherosclerosis in patients with systemic lupus erythematosus. Angiology. 2016;67(8):749–55.
4.
LaurentSBoutouyriePAsmarR. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37(5):1236–41.
5.
DreganA. Arterial stiffness association with chronic inflammatory disorders in the UK Biobank study. Heart. 2018;104(15):1257–62.
6.
YaylaCCanpolatUAkyelA. Association of neutrophil-lymphocyte ratio with impaired aortic elasticity in newly diagnosed and never-treated hypertensive patients. Blood Press Monit. 2015;20(3):127–31.
7.
CelikTYukselUCDemirkolS. Relationship between increased systemic inflammation and impaired aortic elasticity in young patients with prehypertension. Blood Press Monit. 2011;16(2):55–61.
8.
AkbogaYEBektasHAnlarO. Usefulness of platelet to lymphocyte and neutrophil to lymphocyte ratios in predicting the presence of cerebral venous sinus thrombosis and in-hospital major adverse cerebral events. J Neurol Sci. 2017;380:226–9.
9.
BalciKGBalciMMSenF. The role of baseline indirect inflammatory markers in prediction of response to cardiac resynchronisation therapy. Kardiol Pol. 2016;74(2):119–26.
10.
AkbogaMKCanpolatUSahinarslanA. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation. Atherosclerosis. 2015;240(1):110–4.
11.
YilmazSAkbogaMKSenF. Usefulness of the monocyte-to-high-density lipoprotein cholesterol ratio to predict bare metal stent restenosis. Biomark Med. 2016;10(9):959–66.
